|
|
||||||||
Article |

* Department of Immunology, The Scripps Research Institute, La Jolla, California; and
Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois
Correspondence: Dr. Dianne B. McKay, Department of Immunology, IMM-1, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. Phone: 858-784-9716; Fax: 858-784-8069; E-mail: dmckay{at}scripps.edu
Reproductive success is a common, expected outcome for male and female recipients of solid-organ transplants. Men can father children, and women can become pregnant and carry the fetus to delivery. There are, however, important maternal and fetal complications that need to be considered to provide optimal care to the mother and her infant. Although pregnancy is common after the transplantation of all solid organs, guidelines for optimal counseling and clinical management are limited. This review discusses information to help the physician counsel the kidney transplant recipient about risks of pregnancy for the mother and the fetus and provides information to help guide treatment of the pregnant transplant recipient.
This article has been cited by other articles:
![]() |
C. K. Cheung and S. Bhandari The effect of spontaneous twin pregnancy on renal transplant function and haemodynamics NDT Plus, September 23, 2009; (2009) sfp137v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bargman How did cyclophosphamide become the drug of choice for lupus nephritis? Nephrol. Dial. Transplant., February 1, 2009; 24(2): 381 - 384. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |